Brief: Biogen Expands Immunology Pipeline With Agreement To Acquire Raythera Inc.
18/06/2026 24:01
BRIEF-Biogen Expands Immunology Pipeline With Agreement To Acquire Raythera Inc. June 17 (Reuters) - Biogen Inc BIIB.O:
BIOGEN EXPANDS IMMUNOLOGY PIPELINE WITH AGREEMENT TO ACQUIRE RAYTHERA INC.
BIOGEN - TO BUY RAYTHERA FOR UP TO $1 BILLION INCLUDING MILESTONE PAYMENTS
BIOGEN - RAYTHERA LEAD CANDIDATE TO ENTER PHASE 1 DEVELOPMENT IN EARLY Q3 2026
BIOGEN - TO LEAD DEVELOPMENT AND COMMERCIALIZATION OF RAYTHERA ASSETS AFTER CLOSING
Source text: ID:nGNX6Pj1tJ
Further company coverage: BIIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biogen
See all newsHealth Rounds: Old cancer drug may help restore fertility for certain women
U.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
Biogen rises; co scales back drug programs acquired through $5.6 bln Apellis deal
Biogen scales back Apellis programs, trims research roles after $5.6 billion buyout